View in EDS HTML Full Text PDF Full Text

Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium.

Saved in:
Bibliographic Details
Title: Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium.
Authors: Simoens S; KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium., Bento-Abreu A; Merck Sharp & Dohme, Brussels, Belgium., Merckx B; Merck Sharp & Dohme, Brussels, Belgium., Joubert S; Merck Sharp & Dohme, Brussels, Belgium., Vermeersch S; Merck Sharp & Dohme, Brussels, Belgium., Pavelyev A; Merck & Co., Inc., Kenilworth, NJ, United States.; HCL America, Inc., Sunnyvale, CA, United States., Varga S; Merck & Co., Inc., Kenilworth, NJ, United States., Morais E; Merck Sharp & Dohme, Lyon, France.
Source: Frontiers in pharmacology [Front Pharmacol] 2021 Apr 12; Vol. 12, pp. 628434. Date of Electronic Publication: 2021 Apr 12 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33912045
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Simoens+S%22">Simoens S</searchLink>; KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Bento-Abreu+A%22">Bento-Abreu A</searchLink>; Merck Sharp & Dohme, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Merckx+B%22">Merckx B</searchLink>; Merck Sharp & Dohme, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Joubert+S%22">Joubert S</searchLink>; Merck Sharp & Dohme, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Vermeersch+S%22">Vermeersch S</searchLink>; Merck Sharp & Dohme, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Pavelyev+A%22">Pavelyev A</searchLink>; Merck & Co., Inc., Kenilworth, NJ, United States.; HCL America, Inc., Sunnyvale, CA, United States.<br /><searchLink fieldCode="AU" term="%22Varga+S%22">Varga S</searchLink>; Merck & Co., Inc., Kenilworth, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Morais+E%22">Morais E</searchLink>; Merck Sharp & Dohme, Lyon, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2021 Apr 12; Vol. 12, pp. 628434. <i>Date of Electronic Publication: </i>2021 Apr 12 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33912045
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2021.628434
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 628434
    Titles:
      – TitleFull: Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Simoens S
      – PersonEntity:
          Name:
            NameFull: Bento-Abreu A
      – PersonEntity:
          Name:
            NameFull: Merckx B
      – PersonEntity:
          Name:
            NameFull: Joubert S
      – PersonEntity:
          Name:
            NameFull: Vermeersch S
      – PersonEntity:
          Name:
            NameFull: Pavelyev A
      – PersonEntity:
          Name:
            NameFull: Varga S
      – PersonEntity:
          Name:
            NameFull: Morais E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 04
              Text: 2021 Apr 12
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1